Epithelioid Hemangioendothelioma as a Paradigm for Hippo Pathway Dysregulation

Time: 10:00 am
day: Day One

Details:

  • TAZ-CAMTA1 gene fusion is only genetic alteration in epithelioid hemangioendothelioma
  • TAZ-CAMTA1 fusion oncoprotein is a well credentialed target for TEAD inhibitors
  • Epithelioid hemangioendothelioma genetically engineered mouse model is an excellent model for testing TAZ/TEAD inhibitors

Speakers: